Breaking News
November 20, 2018 - Health sector coalition urges Government to safeguard patients in future UK-EU relationship
November 20, 2018 - Study evaluates second-hand marijuana smoke exposure among children
November 20, 2018 - Scientists identify three genes responsible for recurrent molar pregnancies
November 20, 2018 - Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene
November 20, 2018 - Dining Out With Allergies Is Tough, But These Steps Can Help
November 20, 2018 - Breastfeeding protects infants from antibiotic-resistant bacteria
November 20, 2018 - AI matched, outperformed radiologists in screening X-rays for certain diseases | News Center
November 20, 2018 - Adolescents increasingly choose marijuana over cigarettes, alcohol
November 20, 2018 - World’s first medical imaging scanner produces diagnostic scan of the whole human body
November 20, 2018 - Cytocybernetics receives NIMH award to move into neuronal drug development
November 20, 2018 - Recreational drug may help people regain trust in others
November 20, 2018 - Researchers identify gene vital for post-stroke recovery
November 20, 2018 - Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury
November 20, 2018 - Skeletal imitation reveals how bones grow atom-by-atom
November 20, 2018 - Autism behaviors show unique brain network fingerprints in infants
November 20, 2018 - Location matters for inflammation clearance
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Low-protein, high-carb diet may promote healthy brain ageing
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Live probiotics can change existing gut flora and alter immune response
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Personalized program of physical exercise effective in reversing functional decline in the elderly
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
SCHILLER introduces latest generation of ECG device, CARDIOVIT AT-102 G2

SCHILLER introduces latest generation of ECG device, CARDIOVIT AT-102 G2

image_pdfDownload PDFimage_print

With the launch of CARDIOVIT AT-102 G2, SCHILLER is releasing the latest generation of ECG devices.

SCHILLER’s latest ECG device CARDIOVIT AT-102 G2 has been launched. The developers set new standards in electrocardiography with state-of-the-art high-end features, user-friendly design and proven SCHILLER quality for hospitals, clinics and medical practices. Image rights: SCHILLER AG, Photographer Christian Grau

Dr. Michela Perrini, Global Product Manager at SCHILLER in Baar, Switzerland:

In the CARDIOVIT AT-102 G2 we have implemented our many years of experience, customer wishes and optimization possibilities. Our developers have used the latest and best technologies. The device makes a quantum leap in electrocardiography in one fell swoop.”

The first 300 units CARDIOVIT AT-102 G2 have already been shipped. The decision makers of Mehiläinen in Finland reveal the devices key qualities they wanted to adopt in their nationwide institution.

The Swiss medical engineering company SCHILLER launches the latest generation in electrocardiography for hospitals, clinics and medical practices. CARDIOVIT AT-102 G2 features state-of-the-art technology, extremely high operation speed, ease of use, and bi-directional WiFi communication to implement the patient data and send the ECG. The CARDIOVIT AT-102 G2 is equipped with an 8-inch HD color display for quick and effective ECG review. The screen has touch function keys, which, together with the navigation keys, allow a very fast device operation.

Simplifying the daily clinic life

The sophisticated hardware and software make CARDIOVIT AT-102 G2 very fast. The device’s internal memory can accommodate several hundred ECGs. If a record is to be transmitted to an EPA / HIS/ PACS system by WiFi, this can be done in less than a second. This task is what appreciates one of the first customers that bought five units of CARDIOVIT AT-102 G2: Mehiläinen, a nationwide provider of healthcare services in Finland. Kristina Hotakainen, Director of laboratory services at Mehiläinen Oy:

Finnish national recommendations are going to DICOM ECG. So we are updating our ecg process as well as archiving systems. Our long, good and reliable cooperation and experience with SCHILLER systems and devices gave faith in continuity.”

CARDIOVIT AT-102 G2 will be connected with the Mehiläinen Carestream PACS system through the new SCHILLER SEMA. “The automated DICOM workflow is easy and needs a minimum of manual entries”, says Mehiläinen IT Service Engineer Matti Pekka Räsänen. Fast reliable connectivity in the new workflow with minimum manual work in data recording was an important feature for the Mehiläinen decision makers. Paperless fast recording is easy and effective for the Mehiläinen laboratories and occupational nurses.

High speed for greatest efficiency

“In particular, the very fast and very simple operation was a main customer requirement. With CARDIOVIT AT-102 G2, we were able to bring today’s state of the art into medical technology – not an easy task, but we succeeded,” says Dr. Michela Perrini, Global Product Manager at SCHILLER. Using only one navigation key and in three short steps it is possible to download the patient data via PDQ or work list, to record the ECG, and then to save, print and transmit the data.

The device supports paperless workflows, which saves costs. When a paper report is needed, custom printouts can be made from the internal full sized (A4), high-resolution thermal printer. The long battery life makes a single battery charge sufficient for eight hours of ECG recordings during the labor-intensive clinical routine. In addition, CARDIOVIT AT-102 G2 is robust and reliable. The alphanumeric keyboard is sealed and easy to clean, making it easier to comply with the strict hospital hygiene requirements. The trolley’s smoothly running wheels and a handle at the optimum height allows comfortable moving and working. With the standardly mounted storage basket, all important accessories are always at hand.

Proven SCHILLER quality

With its latest innovation, SCHILLER has developed an impressive ECG device with many new features that far exceed the high requirements in the healthcare sector. The body illustration on the large screen shows the exact electrode placement for different configurations. A new function indicates when electrodes have been connected incorrectly. CARDIOVIT AT-102 G2 has highest signal quality, which is especially important for paediatric ECGs. The automatic interpretation provides a reliable analysis of the ECG for both children and adults. Three software options complete CARDIOVIT AT-102 G2: Stress ECG, ETM Sport for the automatic interpretation of the athlete’s heart and CCAA (Culprit Coronary Artery Algorithm).

From a one-man operation to the world’s leading ECG supplier

Company founder Alfred Schiller started his company with ECG devices in the 1970s. To date, a variety of device types have been developed. SCHILLER is one of the world’s leading developers and suppliers of cardiac diagnostics. Currently, more than a dozen ECG devices are available, with special features depending on customer needs, location or the desired accessories. CARDIOVIT AT-102 G2 is the latest electrocardiography product. It is CE approved. The CARDIOVIT AT-102 G2 is produced at the SCHILLER headquarters in Baar, Switzerland.

Tagged with:

About author

Related Articles